Results 41 to 50 of about 5,796 (217)

The Danish National Prescription Registry in studies of a biological pharmaceutical: palivizumab – validation against two external data sources

Clinical Epidemiology, 2015
Ann Haerskjold,1,2 Lonny Henriksen,2 Susanne Way,1 Mikkel Malham,3 Jesper Hallas,4 Lars Pedersen,5 Lone Graff Stensballe1 1The Child and Adolescent Clinic 4072, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark; 2The Research Unit Women&#
Haerskjold A, Henriksen L, Way S, Malham M, Hallas J, Pedersen L, Stensballe LG   +6 more
doaj  

Review of the Safety, Efficacy and Tolerability of Palivizumab in the Prevention of Severe Respiratory Syncytial Virus (RSV) Disease

Drug, Healthcare and Patient Safety, 2023
Shaun O’Hagan,1,2 Niamh Galway,3 Michael D Shields,3,4 Peter Mallett,1,4 Helen E Groves1,2 1Paediatric Infectious Diseases, Royal Belfast Hospital for Sick Children, Belfast, Northern Ireland; 2Wellcome-Wolfson Institute for Experimental Medicine, Queen ...
O'Hagan S, Galway N, Shields MD, Mallett P, Groves HE   +4 more
doaj  

Therapeutic Antibodies for Mosquito‐Borne Orthoflavivirus Infections: Discovery, Engineering Approaches, and Advances in mRNA‐Based Delivery Systems

Advanced Therapeutics, Volume 8, Issue 12, December 2025.
This review explores how antibody engineering and display technologies are driving therapeutic advances against mosquito‐borne orthoflaviviruses such as Zika, dengue, and yellow fever viruses. It highlights diverse neutralizing targets on the envelope protein, including the conserved fusion loop, and discusses how Fc engineering, rational antigen ...
Ana Clara Barbosa Antonelli, Lucas Silva Rodrigues, Maria Clara Moura Pinheiro, Sylvia Barbosa Pinhate, Marcelo de Macedo Brígido, Andréa Queiroz Maranhão   +5 more
wiley   +1 more source

Respiratory Syncytial Virus Epidemiology During and After Covid‐19 Pandemic in Africa: Systematic Review and Meta‐Analysis

Health Science Reports, Volume 8, Issue 12, December 2025.
ABSTRACT Background and Aims Respiratory syncytial virus (RSV) is a major agent of acute respiratory infections in children and the elderly. RSV epidemiology has been changed by the since Covid‐19 pandemic and this review aimed to assess the extent of this change in Africa.
Moussa Issa, Adamou Lagare, Goni A. M. Bachir, Arnol Bowo ‐Ngandji, Fatimata Hassane, Larwanou Harouna Magagi, Doutchi Mahamadou, Haoua Seini, Eric Adehossi, Alzouma Mayaki Zoubeirou   +9 more
wiley   +1 more source

Management of Infants Treated for Respiratory Viral Infections: A Finnish Retrospective Register‐Based Study

Health Science Reports, Volume 8, Issue 11, November 2025.
ABSTRACT Background and Aims Viral respiratory tract infections are common in all age groups, and they are responsible for a vast number of health care visits every year. Furthermore, the incidence of respiratory infections is the highest in children.
Sallamaria Länsisalo, Paula Heikkilä, Sauli Palmu   +2 more
wiley   +1 more source

Palivizumab: Four Seasons in Russia

Annals of the Russian academy of medical sciences, 2014
In 2010, the Russian Federation (RF) registered palivizumab--innovative drug, based on monoclonal antibodies for passive immunization of seasonal respiratory syncytial virus (RSV) infection in children of disease severe progress risk group, which include primarily premature infants, children with bronchopulmonary dysplasia and hemodynamically ...
Baranov A.A., Ivanov D.O., Alyamovskaya G.A., Amirova V.R., Antonyuk I.V., Asmolova G.A., Belyaeva I.A., Bokeriya E.L., Bryukhanova O.A., Vinogradova I.V., Vlasova E.V., Galustyan A.N., Gafarova G.V., Gorev V.V., Davydova I.V., Degtyarev D.N., Degtyareva E.A., Dolgikh V.V., Donin I.M., Zakharova N.I., Zernova L.Yu., Zimina E.P., Zuev V.V., Keshishyan E.S., Kovalev I.A., Koltunov I.E., Korsunskii A.A., Krivoshchekov E.V., Krsheminskaya I.V., Kuznetsova S.N., Lyubimenko V.A., Namazova-Baranova L.S., Nesterenko E.V., Nikolaev S.V., Ovsyannikov D.Yu., Pavlova T.I., Potapova M.V., Rychkova L.V., Safarov A.A., Safina A.I., Skachkova M.A., Soldatova I.G., Turti T.V., Filatova N.A., Shakirova R.M., Yanulevich O.S.   +45 more
openaire   +5 more sources

Respiratory Syncytial Virus (RSV) in an Italian Pediatric Cohort: Genomic Analysis and Circulation Pattern in the Season 2022–2023

Journal of Medical Virology, Volume 97, Issue 11, November 2025.
ABSTRACT There is growing interest in the molecular surveillance of the respiratory syncytial virus (RSV) and data concerning the virus molecular epidemiology in high‐risk pediatric patients in Italy are still limited. A total of 127 RSV‐positive swabs collected in 2022–2023 season were analyzed.
Alessia Lai, Annalisa Bergna, Valentina Fabiano, Carla della Ventura, Hanin Chmes, Alice Romero, Martina Loiodice, Angela Maria Dolores Boria, Alessandro Campagnoli, Felicia Stefania Falvella, Alberto Dolci, Gian Vincenzo Zuccotti, Gianguglielmo Zehender   +12 more
wiley   +1 more source

Risk of RSV-related hospitalization is associated with gestational age in preterm (born at 29–34 wGA) infants without outpatient palivizumab administration

Human Vaccines & Immunotherapeutics, 2023
Palivizumab has been shown to decrease RSV-related hospitalization (RSVH) risk and reduce RSVH severity. American Academy of Pediatrics (AAP) guidance on administration of palivizumab has changed over time; in 2014, palivizumab was no longer recommended ...
Elizabeth R. Packnett, Isabelle H. Winer, Abiola Oladapo, Matthew Wojdyla   +3 more
doaj   +1 more source

Real‐World Effectiveness of Nirsevimab in Preventing RSV Hospitalizations: Evidence of Protection in Southern Italian Infants, 2024–2025

Journal of Medical Virology, Volume 97, Issue 11, November 2025.
ABSTRACT Respiratory syncytial virus (RSV) is a leading cause of hospitalization in infants, resulting in millions of cases and hundreds of thousands of deaths worldwide every year. Nirsevimab, a long‐acting monoclonal antibody approved in 2023, has 75%–90% protection against RSV‐related admissions.
Francesca Fortunato, Rosa Prato, Angelo Acquafredda, Angelo Campanozzi, Valeria Delli Carri, Rosa Francavilla, Giuseppina Iannelli, Pio Liberatore, Gianfranco Maffei, Matteo Mariano, Loris Micelli, Marilena Nesta, Maria Rosa Pastore, Annamaria Calvo, Matteo Rinaldi, Pier Luigi Lopalco, Domenico Martinelli   +16 more
wiley   +1 more source

Efficacy and Safety of Palivizumab as a Prophylaxis for Respiratory Syncytial Virus (RSV) Disease: An Updated Systemic Review and Meta-Analysis [PDF]

, 2023
Khaled El-Atawi, Daniele De Luca, Ranagasamy Ramanathan, Manuel Sánchez Luna, Saad Al-Saedi, Muzafar Gani Abdul Wahab, Moataz Hamdi, Maysa Saleh   +7 more
openalex   +1 more source